Literature DB >> 16236401

The cost-effectiveness of antenatal varicella screening with post-partum vaccination of susceptibles.

A Pinot de Moira1, W J Edmunds, J Breuer.   

Abstract

Varicella infection during pregnancy or around the time of birth can result in serious complications for the mother and/or her child. However, infection during pregnancy is relatively rare as most women are infected during childhood. Immigrant mothers from certain tropical countries are at increased risk of infection, as these countries appear to have lower rates of infection during childhood. We used a cohort model to assess the potential costs and benefits of screening first-time pregnant mothers and then vaccinating those who are susceptible. The model was stratified by age and country of birth (Bangladesh or UK). The strategies evaluated were: (a) an initial verbal screen followed by a serological screen for those with a negative or uncertain history; (b) universal serological screening; and (c) the current strategy which is to treat cases as they arise. Post-partum vaccination was given to those who screen negative for VZV antibodies. The model suggested that the screening and vaccination strategies prevent cases in women compared with the current strategy. Verbal followed by serological screening may be cost-saving to the NHS for both UK- and Bangladesh-born women. Universal screening is more costly but more effective than verbal screening, and it may be cost-effective to universally screen younger immigrant mothers.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16236401     DOI: 10.1016/j.vaccine.2005.09.028

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

Review 1.  Perinatal cytomegalovirus and varicella zoster virus infections: epidemiology, prevention, and treatment.

Authors:  Kristy M Bialas; Geeta K Swamy; Sallie R Permar
Journal:  Clin Perinatol       Date:  2014-11-28       Impact factor: 3.430

2.  The seroepidemiology of varicella zoster virus among pregnant Bangladeshi and white British women in the London Borough of Tower Hamlets, UK.

Authors:  Y S Talukder; G Kafatos; A Pinot de Moira; J Aquilina; S P Parker; N S Crowcroft; D W G Brown; J Breuer
Journal:  Epidemiol Infect       Date:  2007-04-20       Impact factor: 2.451

3.  Follow-up of pregnant women exposed to chicken pox: an audit of relationship between level of antibody and development of chicken pox.

Authors:  E H Boxall; P A C Maple; P Rathod; E Smit
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-01       Impact factor: 5.103

4.  Varicella-zoster immunoglobulin treatment in pregnant women in Denmark from 2005 to 2015: descriptive epidemiology and follow-up.

Authors:  C Jespersen; I G Helmuth; T G Krause
Journal:  Epidemiol Infect       Date:  2016-08-18       Impact factor: 4.434

5.  Immunity to varicella zoster virus among pregnant women in the Norwegian Mother and Child Cohort Study.

Authors:  Grazina Mirinaviciute; Regine Barlinn; Susanne Gjeruldsen Dudman; Elmira Flem
Journal:  PLoS One       Date:  2019-08-13       Impact factor: 3.240

6.  Economic burden of varicella in Europe in the absence of universal varicella vaccination.

Authors:  Manjiri Pawaskar; Estelle Méroc; Salome Samant; Elmira Flem; Goran Bencina; Margarita Riera-Montes; Ulrich Heininger
Journal:  BMC Public Health       Date:  2021-12-21       Impact factor: 3.295

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.